DE69327529D1 - Immunologisch mit HLA homologe HIV Protein Epitope - Google Patents

Immunologisch mit HLA homologe HIV Protein Epitope

Info

Publication number
DE69327529D1
DE69327529D1 DE69327529T DE69327529T DE69327529D1 DE 69327529 D1 DE69327529 D1 DE 69327529D1 DE 69327529 T DE69327529 T DE 69327529T DE 69327529 T DE69327529 T DE 69327529T DE 69327529 D1 DE69327529 D1 DE 69327529D1
Authority
DE
Germany
Prior art keywords
hiv protein
protein epitopes
hla
epitopes
homologous hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69327529T
Other languages
English (en)
Other versions
DE69327529T2 (de
Inventor
Alberto Beretta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fond Mondiale Rech & Prev Sida
Original Assignee
Fond Mondiale Rech & Prev Sida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Mondiale Rech & Prev Sida filed Critical Fond Mondiale Rech & Prev Sida
Publication of DE69327529D1 publication Critical patent/DE69327529D1/de
Application granted granted Critical
Publication of DE69327529T2 publication Critical patent/DE69327529T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE69327529T 1992-05-11 1993-05-10 Immunologisch mit HLA homologe HIV Protein Epitope Expired - Fee Related DE69327529T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM920350A IT1254360B (it) 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
PCT/IT1993/000049 WO1993023427A1 (en) 1992-05-11 1993-05-10 Hiv protein epitopes immunologically homologous to hla

Publications (2)

Publication Number Publication Date
DE69327529D1 true DE69327529D1 (de) 2000-02-10
DE69327529T2 DE69327529T2 (de) 2000-08-10

Family

ID=11400995

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327529T Expired - Fee Related DE69327529T2 (de) 1992-05-11 1993-05-10 Immunologisch mit HLA homologe HIV Protein Epitope

Country Status (7)

Country Link
US (2) US6042831A (de)
EP (1) EP0641357B1 (de)
AT (1) ATE188484T1 (de)
CA (1) CA2135630C (de)
DE (1) DE69327529T2 (de)
IT (1) IT1254360B (de)
WO (1) WO1993023427A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
IT1264078B1 (it) * 1993-09-10 1996-09-10 San Romanello Centro Fond Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus
CN1339320A (zh) * 2000-08-18 2002-03-13 清华大学 一种艾滋病疫苗及其制备方法与应用
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
EP3187585A1 (de) 2010-03-25 2017-07-05 Oregon Health&Science University Cmv-glycoproteine und rekombinante vektoren
PL2691530T3 (pl) 2011-06-10 2019-02-28 Oregon Health & Science University Glikoproteiny i rekombinowane wektory CMV
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
WO2017152144A1 (en) * 2016-03-03 2017-09-08 Duke University Swarm immunization with envelopes from ch505

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943628A (en) * 1988-06-13 1990-07-24 Ortho Pharmaceutical Corporation HIV peptide-inducted T cell stimulation
WO1992005196A1 (en) * 1990-09-25 1992-04-02 Hiver Limited Aids therapy and vaccine
JPH06501260A (ja) * 1990-09-27 1994-02-10 シンテロ ヴァクシーン ディベロップメント ケービー ヒト免疫不全ウィルスに対する中和抗体の誘発とワクチン接種に用いられるペプチド
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Also Published As

Publication number Publication date
EP0641357A1 (de) 1995-03-08
US20020081566A1 (en) 2002-06-27
EP0641357B1 (de) 2000-01-05
ITRM920350A0 (it) 1992-05-11
US6042831A (en) 2000-03-28
IT1254360B (it) 1995-09-14
CA2135630C (en) 2005-03-22
ATE188484T1 (de) 2000-01-15
ITRM920350A1 (it) 1993-11-11
WO1993023427A1 (en) 1993-11-25
DE69327529T2 (de) 2000-08-10
CA2135630A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
DE69327529D1 (de) Immunologisch mit HLA homologe HIV Protein Epitope
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
DK0724432T3 (da) Fremgangsmåder og præparater til mikroindkapsling af antigener til brug som vacciner
DE69534528D1 (de) Mehrstufiger kaskade-erhöhungsimpfstoff
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
DE69131200T2 (de) Herpes simplex virus vp16 impfstoffe
NO870476L (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
DE69720065D1 (de) Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
DK102589D0 (da) Antigen, der genkendes af mca 16-88
DK0537168T3 (da) Antigenet CTAA 28A32, som genkendes af MCA 28A32
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee